Apgar score less than 7 at 5 minutes · pregnant women in latent phase of labour stimulated with oxytocin for with induction of labour. No exclusion criteria were applied in…
Discontinued intravenous (IV) oxytocin stimulation may leads to lower apgar score at five minutes below seven compared with continued IV oxytocin stimulation (low certainty).
1 finding from 1 review
Acidotic cord gasses (arterial umbilical pH < 7.10) · pregnant women in latent phase of labour stimulated with oxytocin for with induction of labour. No exclusion criteria were applied in…
Discontinued intravenous (IV) oxytocin stimulation may leads to higher acidotic cord gasses (arterial umbilical pH < 7.10) compared with continued IV oxytocin stimulation (low certainty).
1 finding from 1 review
Live birth · women undergoing embryo transfer as part of assisted reproduction
Oxytocin antagonists showed no clear difference in live birth compared with control (low certainty).
1 finding from 1 review
Miscarriage · women undergoing embryo transfer as part of assisted reproduction
It is very uncertain whether oxytocin antagonists changes miscarriage compared with control (very low certainty).
1 finding from 1 review
Clinical pregnancy · women undergoing embryo transfer as part of assisted reproduction
Oxytocin antagonists may leads to higher clinical pregnancy compared with control (low certainty).
1 finding from 1 review
Complications · women undergoing embryo transfer as part of assisted reproduction
It is very uncertain whether oxytocin antagonists changes complications compared with control (very low certainty).
1 finding from 1 review
Maternal blood loss of 500 mL or greater · women in the third stage of labour
Oxytocin + ergometrine may leads to lower blood loss 500 mL or more after delivery compared with ergot alkaloids (low certainty).
1 finding from 1 review
Need for additional uterotonics · women in the third stage of labour
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Maternal mortality ‐ not reported · women in the third stage of labour
1 finding from 1 review
Severe PPH (≥ 1000 mL) · women in the third stage of labour
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Blood transfusion · women in the third stage of labour
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Third stage > 30 minutes · women in the third stage of labour
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Diastolic blood pressure > 100 mm Hg between delivery of the baby and discharge from the labour ward · women in the third stage of labour
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Severe PPH (≥ 1000 mL) · management of retained placenta
It is very uncertain whether oxytocin solution changes severe PPH (≥ 1000 mL) compared with expectant management (very low certainty).
1 finding from 1 review
Blood transfusion · management of retained placenta
Oxytocin solution showed no clear difference in blood transfusion compared with expectant management (low certainty).
1 finding from 1 review
Addition of therapeutic uterotonics · management of retained placenta
It is very uncertain whether oxytocin solution changes addition of therapeutic uterotonics compared with expectant management (very low certainty).
1 finding from 1 review
Need for antibiotics · management of retained placenta
It is very uncertain whether oxytocin solution changes need for treatment with antibiotics (infection) compared with expectant management (very low certainty).
1 finding from 1 review
Maternal postpartum anaemia (haemoglobin 24–48 hours postpartum) · management of retained placenta
1 finding from 1 review
Manual removal of the placenta · management of retained placenta
Oxytocin solution may leads to lower manual removal of the placenta compared with saline solution (low certainty).
1 finding from 1 review
Maternal death · management of retained placenta
Oxytocin solution showed no clear difference in maternal mortality compared with saline solution (low certainty).
1 finding from 1 review